Abstract
Pediatric patients undergoing small bowel transplantation are susceptible to postoperative CLABSI. SDD directed against enteric microbes is a strategy for reducing CLABSI. We hypothesized that SDD reduces the frequency of CLABSI, infections outside the bloodstream, and allograft rejection during the first 30 days following transplant. A retrospective chart review of 38 pediatric small bowel transplant recipients at CCHMC from 2003 to 2011 was conducted. SDD antimicrobials were oral colistin, tobramycin, and amphotericin B. The incidence of CLABSI, infections outside the bloodstream, and rejection episodes were compared between study periods. The incidence of CLABSI did not differ between study periods (6.9 CLABSI vs. 4.6 CLABSI per 1000 catheter days; p = 0.727), but gram positives and Candida predominated in the first 30 days. Incidence of bacterial infections outside the bloodstream did not differ (p = 0.227). Rejection occurred more frequently during the first month following transplant (p = 0.302). SDD does not alter the incidence of CLABSI, bacterial infections outside the bloodstream, or allograft rejection in the immediate 30 days post-transplantation. However, SDD does influence CLABSI organism types (favoring gram posi...Continue Reading
References
Jun 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C V Paya, P E Hermans
Mar 1, 1988·Transplantation·R H WiesnerR Krom
Jan 1, 1984·Intensive Care Medicine·C P StoutenbeekD F Zandstra
May 1, 1995·The Journal of Surgical Research·T K LeeW H Schraut
Apr 1, 1995·The Journal of Surgical Research·R BiffiD H Van Thiel
Mar 1, 1993·Transplant International : Official Journal of the European Society for Organ Transplantation·L BarkholtJ Andersson
Jun 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P M ArnowM E Irwin
Nov 20, 1997·Transplantation Proceedings·A HjortrupP Kirkegaard
Mar 14, 1998·Journal of Pediatric Surgery·J ReyesT E Starzl
Jun 13, 1998·Antimicrobial Agents and Chemotherapy·E M JohnsonD W Warnock
Aug 10, 2000·Transplantation·L SigurdssonM Green
Jun 20, 2002·Critical Care Medicine·Jan H ZwavelingMaarten J H Slooff
Jul 20, 2002·Transplantation·Walter C HellingerJeffrey L Steers
Apr 30, 2003·Transplantation·Tong WuA Jake Demetris
Sep 10, 2003·Transplantation Proceedings·C LoinazA Tzakis
Oct 3, 2003·Lancet·Evert de JongeJozef Kesecioglu
Jul 9, 2004·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Nasia SafdarMichael R Lucey
Dec 27, 2005·Transplantation·Giovanni GuaraldiRoberto Esposito
Jan 16, 2007·Transplantation·Phillip RuizAndreas Tzakis
Jun 10, 2008·American Journal of Infection Control·Teresa C HoranMargaret A Dudeck
May 23, 2009·Transplantation Proceedings·A CucchettiA D Pinna
Feb 23, 2010·Transplantation Proceedings·C ZanfiA D Pinna
Apr 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Naomi P O'GradyUNKNOWN Healthcare Infection Control Practices Advisory Committee (HICPAC)
Apr 29, 2011·American Journal of Infection Control·Naomi P O'GradyUNKNOWN Healthcare Infection Control Practices Advisory Committee
Feb 7, 2012·Briefings in Bioinformatics·James A FosterJason H Moore
Nov 10, 2013·PLoS Pathogens·Emily M Mallick, Richard J Bennett
Citations
Mar 3, 2018·Pediatric Transplantation·Jared W ClouseRichard S Mangus
May 17, 2018·Expert Review of Clinical Immunology·Paul J Deziel, Raymund Razonable
May 11, 2018·The Pediatric Infectious Disease Journal·Jared W ClouseRichard S Mangus
Jun 4, 2019·Clinical Transplantation·Saima AslamUNKNOWN AST Infectious Disease Community of Practice